Loading...
Hexima Limited
HXL.AX•ASX
Healthcare
Biotechnology
A$0.01
A$0.00(0.00%)
Hexima Limited (HXL.AX) Financial Performance & Income Statement Overview
Review Hexima Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
69.60%
↑ 69.60%
Net Income Growth
51.33%
↑ 51.33%
Operating Cash Flow Growth
90.82%
↑ 90.82%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-52.59%
↓ 52.59%
ROIC
-44.21%
↓ 44.21%
Hexima Limited (HXL.AX) Income Statement & Financial Overview
Review Hexima Limited's (HXL.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $30837.00 | $66091.00 | $66091.00 |
| Cost of Revenue | $0.00 | $0.00 | $8549.00 | $8549.00 |
| Gross Profit | $0.00 | $30837.00 | $57542.00 | $57542.00 |
| Gross Profit Ratio | $0.00 | $1.00 | $0.87 | $0.87 |
| R&D Expenses | $25566.00 | -$25566.00 | $15395.00 | $7697.00 |
| SG&A Expenses | $516062.00 | $492688.00 | $507796.00 | $41945.00 |
| Operating Expenses | $541628.00 | $467122.00 | $523190.00 | $236856.00 |
| Total Costs & Expenses | $541628.00 | $467122.00 | $523190.00 | $245405.00 |
| Interest Income | $20000.00 | $20785.00 | $20524.00 | $4891.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$2.00 | $2861.00 | $43812.00 | -$39586.00 |
| EBITDA | -$549108.00 | -$467120.00 | -$398086.00 | -$195505.00 |
| EBITDA Ratio | $0.00 | -$15.15 | -$7.92 | -$2.96 |
| Operating Income | -$541628.00 | -$467120.00 | -$523190.00 | -$195505.00 |
| Operating Income Ratio | $0.00 | -$15.15 | -$7.92 | -$2.96 |
| Other Income/Expenses (Net) | -$7476.00 | $20679.00 | $125108.00 | $11300.00 |
| Income Before Tax | -$549104.00 | -$446443.00 | -$398082.00 | -$184205.00 |
| Income Before Tax Ratio | $0.00 | -$14.48 | -$6.02 | -$2.79 |
| Income Tax Expense | -$549104.00 | -$61674.00 | -$29671.00 | $39586.00 |
| Net Income | -$549104.00 | -$384769.00 | -$368411.00 | -$184205.00 |
| Net Income Ratio | $0.00 | -$12.48 | -$5.57 | -$2.79 |
| EPS | -$0.003 | -$0.002 | -$0.002 | -$0.001 |
| Diluted EPS | -$0.003 | -$0.002 | -$0.002 | -$0.001 |
| Weighted Avg Shares Outstanding | $167.04M | $167.04M | $167.04M | $167.16M |
| Weighted Avg Shares Outstanding (Diluted) | $167.04M | $167.04M | $167.04M | $167.04M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan